Femy stock news.

High Growth Earnings: FEMY is forecast to remain unprofitable over the next 3 years. Revenue vs Market: FEMY's revenue (64.4% per year) is forecast to grow faster than the US market (8.1% per year). High Growth Revenue: FEMY's revenue (64.4% per year) is forecast to grow faster than 20% per year.News Femasys Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-0.98 Market Cap $22.30 M Shares Outstanding 21.65 M Public …Fintel. Fintel reports that on September 26, 2023, JonesTrading maintained coverage of Femasys (NASDAQ:FEMY) with a Buy recommendation. Analyst Price Forecast Suggests 1,553.35% Upside As of ...Femasys Inc.is a biomedical company focused on transforming women's healthcare by developing novel solutions as well as providing significant clinical impact to address severely underserved areas. The company's lead product candidates offer FemBloc and FemaSeed. Femasys Inc. is based in ATLANTA. Stock split history for Femasys since 2021.

Femasys Inc (FEMY) $1.03 0.12 (13.19%) 13:00 EST FEMY Stock Quote Delayed 30 Minutes.Webull offers Femasys Inc stock information, including NASDAQ: FEMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FEMY stock news, and many more online research tools to help you make informed decisions.Recent News. The remarkable Femasys (NASDAQ: FEMY) stock price comeback continued on Monday as demand for the shares continued. The shares surged by more than 45% on Friday and gained by another 15% in the pre-market session. It has soared by over 1,257% from the lowest level in September, giving it a market cap of nearly $50 million.

Femasys Stock Earnings. The value each FEMY share was expected to gain vs. the value that each FEMY share actually gained. Femasys ( FEMY) reported Q3 2023 earnings per share (EPS) of -$0.26, missing estimates of -$0.22 by 21.75%. In the same quarter last year, Femasys 's earnings per share (EPS) was -$0.25. Femasys is expected to release next ...Find real-time FEMY - Femasys Inc stock quotes, company profile, news and forecasts from CNN Business.

Zacks Rank: FEMY currently carries a Zacks Rank #3. Femasys Inc. Price and Consensus. Femasys Inc. price-consensus-chart | Femasys Inc. Quote. Stocks to Consider. Here are some stocks in the same ...Get stock insights, analysis and discussion about Femasys Inc (NDAQ:FEMY) ... Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials ...Nov. 13, 2023 5:35 PM ET STRATA Skin Sciences, Inc. (SSKN) By: Urvi Shah, SA News Editor STRATA Skin Sciences ( NASDAQ: SSKN ) is scheduled to announce Q3 earnings results on Tuesday, November ...Shares of FEMY are up on very heavy trading volume. According to data from Benzinga Pro, more than 66 million shares have already been traded on Friday, far exceeding the stock's 100-day average ...

With 11.8mil shares outstanding and a share price of $7.5, the market cap of Femasys is $88.5mil and with a cash position of $33mil, the enterprise value of the company is expected to be $55.5mil ...

Oct 2, 2023 · Recent News. The remarkable Femasys (NASDAQ: FEMY) stock price comeback continued on Monday as demand for the shares continued. The shares surged by more than 45% on Friday and gained by another 15% in the pre-market session. It has soared by over 1,257% from the lowest level in September, giving it a market cap of nearly $50 million.

LAS VEGAS, November 15, 2023--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company") announces it has made a $5 million investment in Femasys, Inc. (Nasdaq:FEMY) ("Femasys"), a biomedical company focused on meeting significant unmet needs for women worldwide. Femasys offers a broad portfolio of in-office, accessible solutions ...Nov 7, 2023 · Femasys Inc ( FEMY) has fallen Tuesday morning, with the stock losing -1.54% in pre-market trading to 1.28. FEMY's short-term technical score of 47 indicates that the stock has traded less bullishly over the last month than 53% of stocks on the market. In the Medical Instruments & Supplies industry, which ranks 80 out of 146 industries, Femasys ... Webull offers Femasys Inc stock information, including NASDAQ: FEMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FEMY stock news, and many more online research tools to help you make informed decisions.FEMY stock closed at $1.11 and is down -$0.04 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. FEMY has a strong overall score of 83 meaning the stock holds a better value than 83% of stocks at its current price.Its stock ran from $0.33 to an intraday high of $4.75 a few days later, only to fall back to the $1 range. During that flurry of activity, the Company used its ATM to raise $11.3M.

Fintel. Fintel reports that on September 26, 2023, JonesTrading maintained coverage of Femasys (NASDAQ:FEMY) with a Buy recommendation. Analyst Price Forecast Suggests 1,553.35% Upside As of ...The public float for FEMY is 19.48M, and currently, short sellers hold a 2.20% ratio of that floaft. The average trading volume of FEMY on November 24, 2023 was 10.08M shares. FEMY’s Market Performance. FEMY’s stock has seen a -9.52% decrease for the week, with a -26.31% drop in the past month and a 141.36% gain in the past quarter.LAS VEGAS, November 15, 2023--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company") announces it has made a $5 million investment in Femasys, Inc. (Nasdaq:FEMY) ("Femasys"), a biomedical company focused on meeting significant unmet needs for women worldwide. Femasys offers a broad portfolio of in-office, accessible solutions ... The latest price target for . Femasys (NASDAQ: FEMY) was reported by HC Wainwright & Co. on Tuesday, November 14, 2023.The analyst firm set a price target for 10.00 expecting FEMY to rise to ...By Eddie Pan, InvestorPlace Financial News Writer Sep 29, 2023, 12:18 pm EST. The cost to borrow T2 Biosystems ( TTOO) tallies in at 37.62%, compared to 16.06% on Sept. 18. Meanwhile, 10% owner CR ...Take a Trial Today. Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20! Get market updates, educational videos, webinars, and stock analysis. Get Started. Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content.

Femasys Stock Earnings. The value each FEMY share was expected to gain vs. the value that each FEMY share actually gained. Femasys ( FEMY) reported Q3 2023 earnings per share (EPS) of -$0.26, missing estimates of -$0.22 by 21.75%. In the same quarter last year, Femasys 's earnings per share (EPS) was -$0.25. Femasys is expected to release next ...

The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the Registration …Nov 28, 2023 · Femasys was founded in 2004 and went public in June 2021 at $13 per share, rising approximately $32M after fees and expenses. The Company then followed the general market downward for the next two... Femasys Inc. (FEMY) stock forecast and price target. Find the latest Femasys Inc. FEMY analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.The company has $10.71 million in cash and $209,098 in debt, giving a net cash position of $10.50 million or $0.66 per share. Cash & Cash Equivalents. 10.71M.Track Femasys Inc (FEMY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

CHRS : 1.5900 (-0.62%) FEMY : 1.2200 (+0.83%) Femasys To Host Key Opinion Leader Event on FemBloc, a First-of-its-Kind Medical Solution for Permanent Birth Control and an Important Option for Women Post Overturn of Roe v. Wade Globe Newswire - Wed Jul 20, 2022. Webinar to be held Thursday, July 28th @ 10:30am EDT...

The stock is up ~205% in after-hours trading on Monday. Femasys (FEMY) says that FeedSeed is "less invasive and more affordable than assisted reproduction procedures, such as in vitro ...

Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods that may have been lost or stolen.Enter your email address below to receive the latest news and earnings results for FEMY and its competitors with MarketBeat's FREE daily newsletter. FEMY Earnings Date and Information Femasys has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 4th, 2024 …Shares of FEMY are up on very heavy trading volume. According to data from Benzinga Pro, more than 66 million shares have already been traded on Friday, far exceeding the stock's 100-day average ...Nov. 30, 2023 8:47 AM ET Femasys Inc. (FEMY) By: Sinchita Mitra, SA News Editor. Femasys ( NASDAQ: FEMY )said it has appointed James Liu as its chief medical officer. Shares in the company down 0. ...View the latest Femasys Inc. (FEMY) stock price, news, historical charts, analyst ratings and financial information from WSJ.Take a Trial Today. Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20! Get market updates, educational videos, webinars, and stock analysis. Get Started. Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content.Femasys Inc. analyst ratings, historical stock prices, earnings estimates & actuals. FEMY updated stock price target summary. Title. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result ... Dec 1, 2023 · Enter your email address below to receive the latest news and earnings results for FEMY and its competitors with MarketBeat's FREE daily newsletter. FEMY Earnings Date and Information Femasys has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 4th, 2024 based off prior year ...

Femasys Inc. FEMY shares are trading lower Tuesday. The stock has been volatile since the company received FDA 510(k) clearance for FemaSeed, an infertility treatment, towards the end of September.. What To Know: On Sept. 26, shares of the stock surged on news of the FDA clearance for FemaSeed, although the stock pulled back the …Nov. 13, 2023 5:35 PM ET STRATA Skin Sciences, Inc. (SSKN) By: Urvi Shah, SA News Editor STRATA Skin Sciences ( NASDAQ: SSKN ) is scheduled to announce Q3 earnings results on Tuesday, November ...Find the latest news headlines from Femasys Inc. Common Stock (FEMY) at Nasdaq.com.11/28/2023 - 08:30 AM - Topline results from FemaSeed ® pivotal trial expected in 1H 2024 - - Commercial launch planned for early 2024 - ATLANTA, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead, late-clinical stage ...Instagram:https://instagram. best reit mutual fundsnvidia healthcarenew ipos todaypopular gold stocks Femasys was founded in 2004 and went public in June 2021 at $13 per share, rising approximately $32M after fees and expenses. The Company then followed …GRCL. Gracell Biotechnologies Inc. 5.05. -0.25. -4.72%. In this piece, we will take a look at the 12 Best Stocks For Day Trading. If you want to skip our introduction to trading indicators and the ... lithium stocksbest server hosts for minecraft That’s a massive surge in trading volume compared to Femasys’ daily average of about 3.3 million shares. FEMY stock is up 180.9% as of Tuesday morning after closing out Monday down 63.2% year ... With a year-over-year growth in debt of -79.53%, FEMASYS INC's debt growth rate surpasses only 2.53% of about US stocks. In terms of volatility of its share price, FEMY is more volatile than 94.29% of stocks we're observing. If you're looking for stocks that are quantitatively similar to FEMASYS INC, a group of peers worth examining would be ... guerbet france Femasys Inc. (Nasdaq: FEMY) gained 510 (k) product clearance for FemaSeed, commenced patient enrollment in the FINALE trial for FemBloc, and raised $11.3 million. The company also achieved compliance with Nasdaq's minimum bid price requirement and announced financial results for Q3 2023.This trend is expected to have continued in the to-be-reported quarter. The Zacks Consensus Estimate for Femasys’ sales in the third quarter of 2023 is pegged at $0.4 million. However, sales in ...Femasys Inc. (Nasdaq: FEMY) gained 510 (k) product clearance for FemaSeed, commenced patient enrollment in the FINALE trial for FemBloc, and raised $11.3 million. The company also achieved compliance with Nasdaq's minimum bid price requirement and announced financial results for Q3 2023.